Health Care

Commentary

Don’t undermine the system that incentivized GLP-1 development

A left-leaning pressure group recently sent a letter to Health and Human Services Secretary Robert F. Kennedy Jr. asking his agency to rescind the patent rights earned by the developers of GLP-1 drugs. Some 12% of U.S. adults have taken these medications. Rescinding the patents is a dangerous idea that ...
Commentary

GOP Can Deliver Affordable Healthcare Americans Demand

Two-thirds of Americans worry about being able to afford healthcare, according to a recent KFF poll. And they’re looking to Washington to do something about it. Republicans have an opportunity to meet that demand — and turn healthcare from a political liability to a policy success. Read the op-ed here.
Commentary

The Legislature shouldn’t decide what vaccines to make illegal

A bill currently making its way through the Idaho Legislature could put the health of countless people at risk. Idaho’s Senate Health Committee recently atdvanced legislation that would impose a two-year moratorium on certain human gene therapy products and ban the use of mRNA vaccines for children and pregnant women ...
Commentary

Trump’s Plan To Peg Drug Prices to Foreign Countries Could Backfire

President Trump famously quipped during his run for a second term that he had “concepts of a plan” to fix health care. That plan finally came together in January — and congressional Republicans are eager to codify its concepts into law. Most of Mr. Trump’s “Great Healthcare Plan” is promising. ...
Commentary

Republicans Haven’t Cut Medicaid—But They Have Tightened Its Belt

Have Republicans cut $1 trillion from Medicaid? Democrats have made this assertion central to their pitch to voters with this fall’s midterm elections approaching. Yet a new report from the nonpartisan Congressional Budget Office tells a different story. According to the agency’s latest projections, spending on Medicaid is set to ...
Commentary

Most-Favored-Nation Pricing Would Import Europe’s Drug Rationing

President Trump’s State of the Union address featured several promising healthcare ideas. Expanding access to patient-owned health savings accounts and routing federal subsidies through them, rather than through insurance companies, would unleash competition by empowering consumers to spend their healthcare dollars as they see fit. So would stronger price transparency ...
Commentary

Why progressives’ single-payer health care dream would bankrupt California

California progressives’ single-payer health care fever dream is back. This time, the cost could hit half a trillion dollars a year. Single-payer means the government pays, for everything. Several candidates for governor are promising just such a government takeover of the state’s health insurance system. Billionaire Tom Steyer says, “Bernie ...
Commentary

Republicans didn’t cut Medicaid — but Democrats did make a mess of it

Democrats are hoping that healthcare will propel them to victory in this year’s midterm elections. Their central charge is that Republicans have cut Medicaid by $1 trillion over 10 years as part of the One Big Beautiful Bill signed into law by President Donald Trump back in July. There’s just ...
Commentary

Republicans already have a plan for making health care affordable in 2026

Affordability is on the lips of lawmakers these days — and with good reason. Nearly half of Americans say they’re struggling to pay for basic necessities like rent, groceries and health care. The good news is that Congress is weighing several reforms that could help make health care in particular ...
commentar

Hospitals Turn a Safety-Net Program Into an ATM

Washington, D.C. is finally taking a hard look at one of the most abuse-ridden federal health programs — the 340B Drug Pricing Program. Last week, the Trump administration released a request for information exploring ways to bring more transparency and accountability to the program. It’s about time.
Commentary

Don’t undermine the system that incentivized GLP-1 development

A left-leaning pressure group recently sent a letter to Health and Human Services Secretary Robert F. Kennedy Jr. asking his agency to rescind the patent rights earned by the developers of GLP-1 drugs. Some 12% of U.S. adults have taken these medications. Rescinding the patents is a dangerous idea that ...
Commentary

GOP Can Deliver Affordable Healthcare Americans Demand

Two-thirds of Americans worry about being able to afford healthcare, according to a recent KFF poll. And they’re looking to Washington to do something about it. Republicans have an opportunity to meet that demand — and turn healthcare from a political liability to a policy success. Read the op-ed here.
Commentary

The Legislature shouldn’t decide what vaccines to make illegal

A bill currently making its way through the Idaho Legislature could put the health of countless people at risk. Idaho’s Senate Health Committee recently atdvanced legislation that would impose a two-year moratorium on certain human gene therapy products and ban the use of mRNA vaccines for children and pregnant women ...
Commentary

Trump’s Plan To Peg Drug Prices to Foreign Countries Could Backfire

President Trump famously quipped during his run for a second term that he had “concepts of a plan” to fix health care. That plan finally came together in January — and congressional Republicans are eager to codify its concepts into law. Most of Mr. Trump’s “Great Healthcare Plan” is promising. ...
Commentary

Republicans Haven’t Cut Medicaid—But They Have Tightened Its Belt

Have Republicans cut $1 trillion from Medicaid? Democrats have made this assertion central to their pitch to voters with this fall’s midterm elections approaching. Yet a new report from the nonpartisan Congressional Budget Office tells a different story. According to the agency’s latest projections, spending on Medicaid is set to ...
Commentary

Most-Favored-Nation Pricing Would Import Europe’s Drug Rationing

President Trump’s State of the Union address featured several promising healthcare ideas. Expanding access to patient-owned health savings accounts and routing federal subsidies through them, rather than through insurance companies, would unleash competition by empowering consumers to spend their healthcare dollars as they see fit. So would stronger price transparency ...
Commentary

Why progressives’ single-payer health care dream would bankrupt California

California progressives’ single-payer health care fever dream is back. This time, the cost could hit half a trillion dollars a year. Single-payer means the government pays, for everything. Several candidates for governor are promising just such a government takeover of the state’s health insurance system. Billionaire Tom Steyer says, “Bernie ...
Commentary

Republicans didn’t cut Medicaid — but Democrats did make a mess of it

Democrats are hoping that healthcare will propel them to victory in this year’s midterm elections. Their central charge is that Republicans have cut Medicaid by $1 trillion over 10 years as part of the One Big Beautiful Bill signed into law by President Donald Trump back in July. There’s just ...
Commentary

Republicans already have a plan for making health care affordable in 2026

Affordability is on the lips of lawmakers these days — and with good reason. Nearly half of Americans say they’re struggling to pay for basic necessities like rent, groceries and health care. The good news is that Congress is weighing several reforms that could help make health care in particular ...
commentar

Hospitals Turn a Safety-Net Program Into an ATM

Washington, D.C. is finally taking a hard look at one of the most abuse-ridden federal health programs — the 340B Drug Pricing Program. Last week, the Trump administration released a request for information exploring ways to bring more transparency and accountability to the program. It’s about time.
Scroll to Top